Baptist Health System/Mid South NCORP Minority Underserved Consortium

描述（由申请人提供）：浸信会社区卫生保健公司（bhcc）的浸信会癌症中心（BCC）代表浸信会卫生系统/中南部NCORP少数族裔/服务不足联盟申请成为NCI社区肿瘤研究计划（NCORP）的少数族裔/服务不足社区站点。该联盟将BCC/BMHCC在孟菲斯市区和周边农村市场的大型综合癌症护理交付项目与城市梅哈里医学院（MCC）项目结合起来，该项目具有少数族裔社区临床肿瘤学项目（MB-CCOP）的经验，并得到了范德比尔特-格林姆癌症中心（VICC）的支持和合作，后者是BCC和MMC在转化临床试验、癌症护理交付和人口研究方面的联合合作伙伴。联合汇水区的人口超过40%是非裔美国人，5%是其他少数民族，约25%是农村人口，是美国最贫穷的人口之一。总的来说，该联盟每年治疗5000多例新的癌症病例。NCORP的投资将支持加强临床试验系统，扩大试验教育和招募服务少数民族和农村人口的实践，并与社区初级保健中心合作进行相关治疗和筛查，预防和其他试验，以及这些社区的癌症护理提供研究。该联盟的提议建立在BMHCC和MMC现有的广泛临床试验和数据管理基础设施的基础上。这两个组织都在其服务不足的地区开展了社区外展和协作初级保健项目。BMHCC还具有良好的癌症护理提供研究（CCDR）基础设施，包括信息技术支持，可访问BMHCC全系统管理和患者数据，以及在所有医院、门诊设施和医生办公室新安装的全系统电子健康记录（EPIC）。BMHCC也有正在进行的NCI和pcori资助的CCDR。联盟领导人在临床试验、MB-CCOPs、癌症数据管理和CCDR方面拥有丰富的经验。该联盟将为所有领域的临床试验做出强有力的贡献，并为NCORP在癌症治疗差异方面的研究议程的发展做出强有力的贡献。

DESCRIPTION (provided by applicant): The Baptist Community Health Care Corporation (BMHCC)'s Baptist Cancer Center (BCC) is applying on behalf of the Baptist Health System/Mid-South NCORP Minority/Underserved Consortium to become a Minority/Underserved Community Site for the NCI Community Oncology Research Program (NCORP). The Consortium brings the BCC/BMHCC's large integrated cancer care delivery program in the urban area of Memphis and surrounding rural markets with the urban Meharry Medical College (MCC) program with its experience as a Minority-Based Community Clinical Oncology Program (MB-CCOP), and the support and collaboration of the Vanderbilt-lngram Cancer Center (VICC), a joint partner of BCC and MMC in translational clinical trials, cancer care delivery, and population research. The joint catchment area's population is over 40% African American, 5% other minority groups, about 25% rural, and among the poorest in the nation. Overall, the Consortium practices treat over 5,000 new cancer cases annually. The NCORP investment will support enhancement of the clinical trials system, outreach for trial education and enrollment in practices serving minority and rural populations, and collaboration with community primary care centers for relevant treatment and screening, prevention and other trials, and in cancer care delivery research in these communities. The Consortium's proposal is built on an existing extensive clinical trial and data management infrastructure at BMHCC and MMC. Both groups have community outreach and collaborative primary care programs in underserved parts of their catchment areas. BMHCC also has an excellent infrastructure for cancer care delivery research (CCDR) including information technology support with access to BMHCC system-wide administrative and patient data, plus a newly installed system-wide electronic health record (EPIC) in all hospitals, ambulatory facilities and physician offices. BMHCC also has ongoing NCI and PCORI-funded CCDR. The Consortium leaders have broad experience in clinical trials, MB-CCOPs, cancer data management and CCDR. The Consortium will be a strong contributor to clinical trials in all areas, and a strong contributor to the development of the NCORP research agenda in cancer care disparities.